View in EDS PDF Full Text

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.

Saved in:
Bibliographic Details
Title: A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.
Authors: Witzig TE; Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN, USA., Laumann KM, Lacy MQ, Hayman SR, Dispenzieri A, Kumar S, Reeder CB, Roy V, Lust JA, Gertz MA, Greipp PR, Hassoun H, Mandrekar SJ, Rajkumar SV
Source: Leukemia [Leukemia] 2013 Jan; Vol. 27 (1), pp. 220-5. Date of Electronic Publication: 2012 Aug 20.
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 22902362
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Witzig+TE%22">Witzig TE</searchLink>; Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Laumann+KM%22">Laumann KM</searchLink><br /><searchLink fieldCode="AU" term="%22Lacy+MQ%22">Lacy MQ</searchLink><br /><searchLink fieldCode="AU" term="%22Hayman+SR%22">Hayman SR</searchLink><br /><searchLink fieldCode="AU" term="%22Dispenzieri+A%22">Dispenzieri A</searchLink><br /><searchLink fieldCode="AU" term="%22Kumar+S%22">Kumar S</searchLink><br /><searchLink fieldCode="AU" term="%22Reeder+CB%22">Reeder CB</searchLink><br /><searchLink fieldCode="AU" term="%22Roy+V%22">Roy V</searchLink><br /><searchLink fieldCode="AU" term="%22Lust+JA%22">Lust JA</searchLink><br /><searchLink fieldCode="AU" term="%22Gertz+MA%22">Gertz MA</searchLink><br /><searchLink fieldCode="AU" term="%22Greipp+PR%22">Greipp PR</searchLink><br /><searchLink fieldCode="AU" term="%22Hassoun+H%22">Hassoun H</searchLink><br /><searchLink fieldCode="AU" term="%22Mandrekar+SJ%22">Mandrekar SJ</searchLink><br /><searchLink fieldCode="AU" term="%22Rajkumar+SV%22">Rajkumar SV</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2013 Jan; Vol. 27 (1), pp. 220-5. <i>Date of Electronic Publication: </i>2012 Aug 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22902362
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/leu.2012.236
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 220
    Titles:
      – TitleFull: A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Witzig TE
      – PersonEntity:
          Name:
            NameFull: Laumann KM
      – PersonEntity:
          Name:
            NameFull: Lacy MQ
      – PersonEntity:
          Name:
            NameFull: Hayman SR
      – PersonEntity:
          Name:
            NameFull: Dispenzieri A
      – PersonEntity:
          Name:
            NameFull: Kumar S
      – PersonEntity:
          Name:
            NameFull: Reeder CB
      – PersonEntity:
          Name:
            NameFull: Roy V
      – PersonEntity:
          Name:
            NameFull: Lust JA
      – PersonEntity:
          Name:
            NameFull: Gertz MA
      – PersonEntity:
          Name:
            NameFull: Greipp PR
      – PersonEntity:
          Name:
            NameFull: Hassoun H
      – PersonEntity:
          Name:
            NameFull: Mandrekar SJ
      – PersonEntity:
          Name:
            NameFull: Rajkumar SV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2013 Jan
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5551
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Leukemia
              Type: main
ResultId 1